欧美激情一区二区三区视频 ,性导航天天精品,日本欧美一区二区,日本一区二区视频在线观看,国产激情久久久久99蜜桃,国产成人一区二区三区高清,亚洲久久久久AV无码,天天日天天操天天淫

公司簡(jiǎn)介
珂闌醫(yī)藥概況

珂闌(上海)醫(yī)藥科技有限公司 Cholesgen (Shanghai) Co. Ltd. 成立于2021年,是致力于開(kāi)發(fā)源頭創(chuàng)新藥物的生物醫(yī)藥公司。公司聚焦疾病新型靶標(biāo),以生物化學(xué)、疾病生物學(xué)、藥物化學(xué)及臨床轉(zhuǎn)化醫(yī)學(xué)為基礎(chǔ),開(kāi)展針對(duì)代謝性疾病(高脂血癥、肥胖癥、糖尿病、動(dòng)脈粥樣硬化癥以及NASH等)和腫瘤等重大疾病的創(chuàng)新型醫(yī)藥研發(fā)工作。 公司創(chuàng)始團(tuán)隊(duì)包括來(lái)自國(guó)內(nèi)外頂尖藥企的研發(fā)精英和來(lái)自國(guó)內(nèi)頂尖科研院所的研究骨干,顧問(wèn)團(tuán)隊(duì)包括來(lái)自國(guó)內(nèi)外代謝領(lǐng)域以及生命科學(xué)和藥物化學(xué)等相關(guān)領(lǐng)域的資深科學(xué)家和教授。珂闌醫(yī)藥將從獨(dú)特新穎的研發(fā)視角出發(fā),構(gòu)建差異化的研發(fā)管線,基于代謝性疾病和腫瘤研究的全新機(jī)理,圍繞全新靶點(diǎn)展開(kāi)多條管線的新型藥物研發(fā)。珂闌醫(yī)藥關(guān)注人類健康重大疾病,將融合生命科學(xué)、藥物化學(xué)、臨床醫(yī)學(xué)等核心技術(shù),構(gòu)建自主創(chuàng)新研發(fā)平臺(tái),為代謝性疾病和腫瘤治療提供極具潛力的創(chuàng)新型藥物。
核心團(tuán)隊(duì)
戚煒 科學(xué)顧問(wèn)

上海科技大學(xué)研究員

戚煒 科學(xué)顧問(wèn)
戚煒博士,曾任職于諾華生物醫(yī)學(xué)研究中心,有超過(guò)15年的新藥研發(fā)和團(tuán)隊(duì)管理經(jīng)驗(yàn),在學(xué)術(shù)界和工業(yè)界領(lǐng)導(dǎo) 推動(dòng)了多個(gè)新藥研發(fā)項(xiàng)目,其中3個(gè)項(xiàng)目通過(guò)不同方式進(jìn)入IND申報(bào)和臨床試驗(yàn)。戚煒博士供職于上海科技大學(xué),擔(dān)任研究員、博士生導(dǎo)師,上海市千人計(jì)劃獲得者,并擔(dān)任生命學(xué)院科研成果轉(zhuǎn)化委員會(huì)主席。
宋保亮 中國(guó)科學(xué)院院士 科學(xué)顧問(wèn)

武漢大學(xué)教授

宋保亮 中國(guó)科學(xué)院院士 科學(xué)顧問(wèn)
武漢大學(xué)教授, 兼任中國(guó)細(xì)胞生物學(xué)學(xué)會(huì)理事長(zhǎng)、基金委糖脂代謝重大研究計(jì)劃專家組組長(zhǎng)。 獲陳嘉庚青年科學(xué)獎(jiǎng)、中國(guó)青年科技獎(jiǎng)、科學(xué)探索獎(jiǎng)等榮譽(yù)。 本科畢業(yè)于南京大學(xué),在中科院上海生科院生化細(xì)胞所獲博士學(xué)位,在美國(guó)西南醫(yī)學(xué)中心Michael Brown & Joseph Goldstein(1985年諾獎(jiǎng)得主)實(shí)驗(yàn)室從事博士后研究。隨后在中科院上海生科院生化與細(xì)胞所,任研究組長(zhǎng)。 2014起在武漢大學(xué)生命科學(xué)學(xué)院任教授(2014-2022 任生命科學(xué)學(xué)院院長(zhǎng))。
唐靜潔 生物部總監(jiān)

唐靜潔 生物部總監(jiān)
博士,畢業(yè)于中科院分子細(xì)胞科學(xué)卓越創(chuàng)新中心(原生化與細(xì)胞所),師從宋保亮院士。曾任職于中科院生化與細(xì)胞所,在Cell Metabolism、Molecular Cell、Clinical Cancer Research、Nature Communications、Plos Genetics等國(guó)際學(xué)術(shù)期刊發(fā)表多篇研究論文,主持并完成包括國(guó)家自然科學(xué)基金面上項(xiàng)目在內(nèi)的多項(xiàng)基金項(xiàng)目。入選2022東方英才計(jì)劃和2024浦東新區(qū)明珠菁英人才計(jì)劃。有近20年膽固醇代謝調(diào)控機(jī)制及相關(guān)生理病理功能研究經(jīng)歷,有豐富的藥物篩選、藥理藥效研究經(jīng)驗(yàn)和項(xiàng)目管理、團(tuán)隊(duì)管理經(jīng)驗(yàn)。
劉金鏢 化學(xué)部總監(jiān)

劉金鏢 化學(xué)部總監(jiān)
本科與研究生均就讀于華東師范大學(xué),并獲得有機(jī)化學(xué)碩士學(xué)位。擁有近20年的新藥研發(fā)與合成的經(jīng)歷。先后任職于上海藥明康德, 諾華(中國(guó))生物醫(yī)學(xué)研究中心和石藥上海研發(fā)中心。曾參與多個(gè)新藥研發(fā)的藥化設(shè)計(jì)及化學(xué)合成,具有豐富新藥藥物化學(xué)經(jīng)驗(yàn)和有機(jī)合成能力。目前參與的多個(gè)項(xiàng)目均已經(jīng)申請(qǐng)專利,其中一個(gè)項(xiàng)目目前正處于一期臨床階段。
過(guò)瑩立 運(yùn)營(yíng)部高級(jí)總監(jiān)

過(guò)瑩立 運(yùn)營(yíng)部高級(jí)總監(jiān)
碩士畢業(yè)于中國(guó)科學(xué)技術(shù)大學(xué),并獲得曼徹斯特大學(xué)工商管理碩士。曾供職于上海睿星基因,以及賽默飛世爾,艾昆緯等世界500強(qiáng)企業(yè)。超過(guò)20年醫(yī)藥行業(yè)研發(fā)經(jīng)驗(yàn),有豐富的商務(wù)合作及運(yùn)營(yíng)經(jīng)驗(yàn)。
郝欣 化學(xué)部副總裁

郝欣 化學(xué)部副總裁
博士,本科畢業(yè)于北京大學(xué)化學(xué)系,在美國(guó)university of Colorado-Boulder 獲得有機(jī)化學(xué)博士學(xué)位。曾于葛蘭素史克上海研發(fā)中心,諾華生物醫(yī)藥研究中心,及瑞石生物醫(yī)藥等公司任職。曾領(lǐng)導(dǎo)藥化團(tuán)隊(duì)完成多個(gè)項(xiàng)目的PCC,并推動(dòng)其中兩個(gè)項(xiàng)目獲得IND臨床許可,具有豐富的新藥研發(fā)和團(tuán)隊(duì)管理經(jīng)驗(yàn)。并在2024入選浦東新區(qū)明珠菁英人才計(jì)劃。
學(xué)術(shù)研究

Wang JQ, Li LL, Hu A, Deng G, Wei J, Li YF, Liu YB, Lu XY, Qiu ZP, Shi XJ, Zhao X, Luo J, Song BL*. Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion. Nature. 2022, 608(7922):413-420

Wang JK, Li Y, Zhao XL, Liu YB, Tan J, Xing YY, Adi D, Wang YT, Fu ZY, Ma YT, Liu SM, Liu Y, Wang Y, Shi XJ, Lu XY, Song BL*, Luo J*. Ablation of Plasma Prekallikrein Decreases LDL Cholesterol by Stabilizing LDL Receptor and Protects against Atheroscleros

Qiu ZP, Lin ZC, Hu A, Liu YB, Zeng WE, Zhao X, Shi XJ, Luo J, Song BL*. GRAMD1/ASTER-mediated cholesterol transport promotes Smoothened cholesterylation at the endoplasmic reticulum. EMBO J. 2022, doi: 10.15252/embj.2022111513. Online ahead of print.

Hu A, Zhang JZ, Wang J, Li CC, Yuan M, Deng G, Lin ZC, Qiu ZP, Liu HY, Wang XW, Wei PC, He X, Zhao X*, Qiu WW*, Song BL*. Cholesterylation of Smoothened is a calcium-accelerated autoreaction involving an intramolecular ester intermediate. Cell Res. 32(3):

Jiang SY, Yang X, Yang Z, Li JW, Xu MQ, Qu YX, Tang JJ, Li YF, Wang L, Shao YW, Meng XY, Hu H, Song BL*, Rao Y*, Qi W*. Discovery of a INSIG binding compound that ameliorates nonalcoholic steatohepatitis by inhibiting SREBP-mediated lipogenesis. Hepatolog

Kong Z, Xu M, Zhang Y, Huang W, Zhao X, Luo J, Song BL*. The cation-π interaction in cysteine-rich domain of Smoothened is critical for its cholesterylation and function. Acta Biochim Biophys Sin (Shanghai). 54(8):1171-1179. doi: 10.3724/abbs.2022090. 202

Luo J, Wang JK, Song BL*. Lowering low-density lipoprotein cholesterol: from mechanisms to therapies. Life Metabolism, https://doi.org/10.1093/lifemeta/loac004, 1(1): 25-38, 2022

Hu A, Zhou M, Song BL*. Analysis of Protein Cholesterylation by Biorthogonal Labeling. Methods Mol Biol. 2374:27-36, 2022

Qiu ZP, Hu A, Song BL*. The 3-beta-hydroxysteroid-Delta(8), Delta(7)-isomerase EBP inhibits cholesterylation of Smoothened. Biochim Biophys Acta Mol Cell Biol Lipids. 1866(12):159041, 2021

Luo J, Liu YB, Song BL*. Hitching a ride to the top: peroxisomes fuel cilium with cholesterol. Sci China Life Sci. 64(3): 478-481, 2021

Lu XY#, Shi XJ#, Hu A#, Wang JQ#, Ding Y, Jiang W, Sun M, Zhao X, Luo J, Qi W and Song BL*. Feeding induces cholesterol biosynthesis via the mTORC1–USP20–HMGCR axis. Nature. 588(7838): 479-484, 2020

Luo J, Yang H, Song BL*. Mechanisms and regulation of cholesterol homeostasis. Nature Reviews Molecular Cell Biology. 21(4): 225-245, 2020

Zhou ZS#, Li MX#, Liu J#, Jiao H, Xia JM, Shi XJ, Zhao H, Chu L, Liu J, Qi W, Luo J, Song BL*. Competitive oxidation and ubiquitylation on the evolutionarily conserved cysteine confer tissue-specific stabilization of Insig-2. Nature Communications. 11(1):

Xiao J, Xiong Y, Yang LT, Wang JQ, Zhou ZM, Dong LW, Shi XJ, Zhao X, Luo J and Song BL*. POST1/C12ORF49 regulates the SREBP pathway by promoting site-1 protease maturation. Protein Cell. 2020 Jul 14. doi: 10.1007/s13238-020-00753-3. Online ahead of print.

Gong XM#, Li YF#, Luo J#, Wang JQ#, Wei J#, Wang JQ, Xiao T, Xie C, Hong J, Ning G, Shi XJ, Li BL, Qi W*, Song BL*. Gpnmb secreted from liver promotes lipogenesis in white adipose tissue and aggravates obesity and insulin resistance. Nature Metabolism, 1:

Xiao J#, Luo J#, Hu A, Xiao T, Li M, Kong Z, Jiang L, Zhou Z, Liao Y, Xie C, Chu B, Miao H, Li B, Shi X, Song BL*. Cholesterol transport through the peroxisome-ER membrane contacts tethered by PI(4,5)P2 and extended synaptotagmins. Sci China Life Sci. 62(

Luo J, Jiang LY, Yang H, Song BL*. Intracellular cholesterol transport by sterol transfer proteins at membrane contact sites. Trends in Biochemical Sciences (Invited review), 44(3): 273-292, 2019

Hu A, Song BL*. The interplay of Patched, Smoothened and cholesterol in Hedgehog signaling. Curr Opin Cell Biol. 61: 31-38, 2019

Jiang SY#, Tang JJ#, Xiao X, Qi W, Wu S, Jiang C, Hong J, Xu J*, Song BL*, Luo J*. Schnyder corneal dystrophy-associated UBIAD1 mutations cause corneal cholesterol accumulation by stabilizing HMG-CoA reductase. PLoS Genet. 15(7): e1008289, 2019

Chen L, Ma MY, Sun M, Jiang LY, Zhao XT, Fang XX, Lam SM, Shui GH, Luo J, Shi XJ, Song BL*. Endogenous sterol intermediates of the mevalonate pathway regulate HMG-CoA reductase degradation and SREBP-2 processing. J Lipid Res. 2019 Aug 27. pii: jlr.RA11900

Chen L*, Chen XW*, Huang X*, Song BL*, Wang Y*, Wang Y*. Regulation of glucose and lipid metabolism in health and disease. Sci China Life Sci. 62(11):1420-1458, 2019

Zhang YY#, Fu ZY#, Wei J#, Qi W, Baituola G, Luo J, Meng YJ, Guo SY, Yin H, Jiang SY, Li YF, Miao HH, Liu Y, Wang Y, Li BL, Ma YT*, Song BL*. A LIMA1 variant promotes low plasma LDL cholesterol and decreases intestinal cholesterol absorption. Science, 360

Jiang SY#, Li H#, Tang JJ#, Wang J, Luo J, Liu B, Wang JK, Shi XJ, Cui HW, Tang J, Yang F, Qi W, Qiu WW*, Song BL*. Discovery of a potent HMG-CoA reductase degrader that eliminates statin-induced reductase accumulation and lowers cholesterol. Nature Commu

Liao YC#, Wei J#, Wang J, Shi XJ, Luo J, Song BL*. The non-canonical NF-κB pathway promotes NPC2 expression and regulates intracellular cholesterol trafficking. Science China Life Sciences, 61(10): 1222-1232, 2018

Jiang LY#, Jiang W#, Tian N, Xiong YN, Liu J, Wei J, Wu KY, Luo J, Shi XJ*, Song BL*. Ring finger protein 145 (RNF145) is a ubiquitin ligase for sterol-induced degradation of HMG-CoA reductase. Journal of Biological Chemistry., ??293(11): 4047-4055, 2018

Hu A, Zhao XT, Tu H, Xiao T, Fu T, Wang Y, Liu Y, Shi XJ, Luo J*, Song BL*. PIP4K2A regulates intracellular cholesterol transport through modulating PI(4,5)P2 homeostasis. Journal of Lipid Research, 59(3): 507-514, 2018

Wang YJ, Bian Y, Luo J, Lu M, Xiong Y, Guo SY, Yin HY, Lin X, Li Q, Chang CCY, Chang TY, Li BL*, Song BL*. Cholesterol and fatty acids regulate cysteine ubiquitination of ACAT2 through competitive oxidation. Nature Cell Biology, 19(7): 808-819, 2017

Xiao X#, Tang JJ#, Peng C, Wang Y, Fu L, Qiu ZP, Xiong Y, Yang LF, Cui HW, He XL, Yin L, Qi W, Wong CC, Zhao Y, Li BL, Qiu WW*, Song BL*. Cholesterol modification of smoothened is required for hedgehog signaling. Molecular Cell, 66(1): 154-162, 2017

Li N, Zhou ZS, Shen Y, Xu J, Miao HH, Xiong Y, Xu F, Li BL, Luo J, Song BL*. Inhibition of the SREBP pathway suppresses hepatocellular carcinoma through repressing inflammation. Hepatology, 65(6): 1936-1947, 2017

Wei J#, Zhang YY#, Luo J, Wang JQ, Zhou YX, Miao HH, Shi XJ, Qu YX, Xu J, Li BL, Song BL*. The GARP complex is involved in intracellular cholesterol transport via targeting NPC2 to lysosomes. Cell Reports, 19(13): 2823-2835, 2017

Luo J, Jiang L, Yang H, Song BL*. Routes and mechanisms of post-endosomal cholesterol trafficking: a story that never ends. Traffic (Invited review), 18(4): 209-217, 2017

Xie C#, Gong XM#, Luo J, Li BL, Song BL*. AAV9-NPC1 significantly ameliorates Purkinje cell death and behavioral abnormalities in mouse Niemann-Pick type C disease. Journal of Lipid Research, 58(3): 512-518, 2017

Xie C#, Zhang YP#, Song L#, Luo J, Qi W, Hu J, Lu D, Yang Z, Zhang J, Xiao J, Zhou B, Du JL, Jing N, Liu Y, Wang Y, Li BL, Song BL*, Yan Y*. Genome editing with CRISPR/Cas9 in postnatal mice corrects PRKAG2 cardiac syndrome. Cell Research, 26(10): 1099-11

Chu BB#, Liao YC#, Qi W, Xie C, Du X, Wang J, Yang H, Miao HH, Li BL, Song BL*. Cholesterol transport through lysosome-peroxisome membrane contacts. Cell, 161(2): 291-306, 2015

Li PS, Fu ZY, Zhang YY, Zhang JH, Xu CQ, Ma YT, Li BL, Song BL*. The clathrin adaptor Numb regulates intestinal cholesterol absorption through dynamic interaction with NPC1L1. Nature Medicine, 20(1): 80-86. 2014

Wei J#, Fu ZY#, Li PS#, Miao HH, Li BL, Ma YT*, Song BL*. The clathrin adaptor proteins ARH, Dab2, and numb play distinct roles in Niemann-Pick C1-Like 1 versus low density lipoprotein receptor-mediated cholesterol uptake. Journal of Biological Chemistry,

Jiang W, Tang JJ, Miao HH, Qu YX, Qin J, Xu J, Yang J*, Li BL, Song BL*. Forward genetic screening for regulators involved in cholesterol synthesis using validation-based insertional mutagenesis. PLoS One, 9(11): e112632, 2014

Lu M#, Hu XH#, Li Q, Xiong Y, Hu GJ, Xu JJ, Zhao XN, Wei XX, Chang CC, Liu YK, Nan FJ, Li J, Chang TY, Song BL*, Li BL*. A specific cholesterol metabolic pathway is established in a subset of HCCs for tumor growth. Journal of Molecular Cell Biology, 5(6):

Liu TF, Tang JJ, Li PS, Shen Y, Li JG, Miao HH, Li BL*, Song BL*. Ablation of gp78 in liver improves hyperlipidemia and insulin resistance by inhibiting SREBP to decrease lipid biosynthesis. Cell Metabolism, 16(2): 213-225, 2012

Xie C#, Zhou ZS#, Li N, Bian Y, Wang YJ, Wang LJ, Li BL*, Song BL*. Ezetimibe blocks the internalization of NPC1L1 and cholesterol in mouse small intestine. Journal of Lipid Research, 53(10): 2092-2101, 2012

Wang LJ, Song BL*. Niemann-Pick C1-Like 1 and cholesterol uptake. Biochimica et Biophysica Acta (Invited review), 1821(7): 964-972, 2012

Tang JJ#, Li JG#, Qi W, Qiu WW, Li PS, Li BL, Song BL*. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques. Cell Metabolism, 13(1): 44-56, 2011

Ge L, Qi W, Wang LJ, Miao HH, Qu YX, Li BL, Song BL*. Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake. Proceedings of the National Academy of Sciences of the United States of America, 108(2): 551-556, 2011

Xie C, Li N, Chen ZJ, Li BL, Song BL*. The small GTPase Cdc42 interacts with Niemann-Pick C1-like 1 (NPC1L1) and controls its movement from endocytic recycling compartment to plasma membrane in a cholesterol-dependent manner. Journal of Biological Chemist

Zhang JH#, Ge L#, Qi W, Zhang L, Miao HH, Li BL, Yang M, Song BL*. The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake. Journal of Biological Chemistry, 286(28): 25088-25097, 2011

Wang LJ, Wang J, Li N, Ge L, Li BL, Song BL*. Molecular characterization of the NPC1L1 variants identified from cholesterol low absorbers. Journal of Biological Chemistry, 286(9): 7397-7408, 2011

Miao HH, Jiang W, Ge L, Li BL, Song BL*. Tetra-glutamic acid residues adjacent to Lys248 in HMG-CoA reductase are critical for the ubiquitination mediated by gp78 and UBE2G2. Acta Biochimica et Biophysica Sinica, 42(5): 303-310, 2010

Chu BB#, Ge L#, Xie C, Zhao Y, Miao HH, Wang J, Li BL, Song BL*. Requirement of myosin Vb.Rab11a.Rab11-FIP2 complex in cholesterol-regulated translocation of NPC1L1 to the cell surface. Journal of Biological Chemistry, 284(33): 22481-22490, 2009

Wang J, Chu BB, Ge L, Li BL, Yan Y*, Song BL*. Membrane topology of human NPC1L1, a key protein in enterohepatic cholesterol absorption. Journal of Lipid Research, 50(8): 1653-1662, 2009

Ge L#, Wang J#, Qi W#, Miao HH, Cao J, Qu YX, Li BL, Song BL*. The cholesterol absorption inhibitor ezetimibe acts by blocking the sterol-induced internalization of NPC1L1. Cell Metabolism, 7(6): 508-519, 2008

Qi W, Song BL*. Dissecting the NPC1L1-mediated cholesterol absorption. Future Lipidology (Invited review), 3: 481-484, 2008

Cao J, Wang J, Qi W, Miao HH, Wang J, Ge L, DeBose-Boyd RA, Tang JJ, Li BL*, Song BL*. Ufd1 is a cofactor of gp78 and plays a key role in cholesterol metabolism by regulating the stability of HMG-CoA reductase. Cell Metabolism, 6(2): 115-128, 2007

Song BL*, DeBose-Boyd RA*. Insig-dependent ubiquitination and degradation of 3-hydroxy-3-methylglutaryl coenzyme a reductase stimulated by delta- and gamma-tocotrienols. Journal of Biological Chemistry, 281(35): 25054-25061, 2006

珂闌大事記
2021
2021

ATLATL實(shí)驗(yàn)室啟用;

入駐ATLATL辦公室;

第一批化合物交付;

首家CRO啟動(dòng);

第一次全體大會(huì);

正式開(kāi)始辦公;

2023
2023

6月,珂闌醫(yī)藥與阿斯利康達(dá)成新藥研發(fā)合作協(xié)議;

9月,阿斯利康與珂闌醫(yī)藥聯(lián)合舉行了簽約慶祝儀式。

12月,珂闌醫(yī)藥迎來(lái)了喜遷新居的好日子,正式搬遷到上海市浦東上科路88號(hào)豪威科技園。

2021 2023